NewLink Genetics (NLNK) Strengthens Patent on Cancer Therapy D-1MT
Go back to NewLink Genetics (NLNK) Strengthens Patent on Cancer Therapy D-1MTNEWLINK GENETICS (NASDAQ: NLNK) | Delayed: 0.89 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.89 | 52 Week High | $38.92 | |||
Open | $5.96 | 52 Week Low | $9.23 | |||
Day High | $0.89 | P/E | N/A | |||
Day Low | $0.89 | EPS | $-1.23 | |||
Volume | 77 |